ZL-6201

Zai Lab (Shanghai) Co., Ltd. · Phase 1 active Small molecule

At a glance

Generic name	ZL-6201
Sponsor	Zai Lab (Shanghai) Co., Ltd.
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

ZL-6201 CI brief — competitive landscape report
ZL-6201 updates RSS · CI watch RSS
Zai Lab (Shanghai) Co., Ltd. portfolio CI